No affiliation or endorsement is implied
It supports energy metabolism and may contribute to healthy sperm function
FDA states that ConjuChem Biotechnology withdrew CJC-1295 DAC from clinical trials in 2006 after the death of a subject involved in a phase 2 trial, and describes it: two hours after receiving an eleventh weekly dose, one subject complained of chest discomfort, an ECG confirmed an acute myocardial infarction, and the subject died approximately one hour later
an event characterized by loss of cell membrane asymmetry, cell shrinkage, and an increase in intracellular Ca 2+ , primarily due to dysregulated Ca 2+ influx [436]
M.TsaiE
Heat, moisture, oxygen exposure, light, and repeated warming can still reduce quality over time